# The PROMISE Survey

> **NCT06936813** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 530 (actual)

## Conditions studied

- Prolactinoma
- Pituitary Tumor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06936813
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-03-30
- **Target enrollment:** 530 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06936813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06936813, "The PROMISE Survey". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06936813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*